Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
September, 2024
September 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« Aug
vivek subbiah
Oct 5, 2023, 17:42 |
Insight
Vivek Subbiah: Still remember the 1st ever patient enrolled on the trial in the peak of the pandemic.
Quoting Vivek Subbiah, Chief of Early-Phase Drug Development at The Sarah Cannon Research Institute, on…
Oct 5, 2023, 17:41 |
Blog
Vivek Subbiah: Mark your calendars if you are attending the ESMO MAP23 meeting in Paris, France this week, Oct 4-6.
Quoting Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, on…
Oct 3, 2023, 18:02 |
Insight
Vivek Subbiah: Delighted to publish our editorial. TRKing sarcomas for precision medicine: Seek, and ye shall find! In the American Cancer Society Journal Cancer.
Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, shared on X/Twitter:…
Oct 2, 2023, 18:31 |
Opinion
Vivek Subbiah: What a fantastic meeting packed with everything that’s needed for an early-phase drug development program.
Quoting Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, on LinkedIn:…
Oct 1, 2023, 16:07 |
Blog
Vivek Subbiah: Fantastic keynote lecture on “The FDA perspective on early phase pre-market dose optimization” by the amazing Dr. Paul Kluetz.
Vivek Subbiah shared on X/Twitter: “Fantastic keynote lecture on “The FDA perspective on early phase pre-market…
Oct 1, 2023, 00:34 |
Positive
Vivek Subbiah: Can oncologists kick a football? Of course they kick cancer every day.
Oncologists are excited about an upcoming football event. "Finally 'Habemus football' after successful last SOCCER-ASCO#23…
Sep 29, 2023, 18:30 |
Blog
Vivek Subbiah: Thanks to Ishwaria Subbiah for discussing this crucial topic with the US Social Security Administration.
Vivek Subbiah shared a post by Ishwaria Subbiah on LinkedIn, adding: ''Cancer is the 2nd…
Sep 28, 2023, 20:32 |
Blog
Vivek Subbiah: So much enthusiasm for delivering Precision Medicine every where.
Vivek Subbiah, made the following post on LinkedIn: "Delighted to visit Park City, Utah to deliver…
Sep 26, 2023, 19:21 |
Insight
Vivek Subbiah: A clinical trial is not a last resort but can be a first option for people facing cancer.
Vivek Subbiah, Chief, Early-Phase Drug Development at Sarah Cannon Research Institute, shared a post by…
Sep 24, 2023, 17:52 |
Blog
Vivek Subbiah: Great honor to meet with the amazing and beloved The Nobel Prizewinner Dr. Bill Kaelin Dana-Farber Cancer Institute.
Vivek Subbiah, Chief, Early-Phase Drug Development at Sarah Cannon Research Institute, shared on LinkedIn: ''Great…
22
23
24
25
26
All:
341
Posts:
231 - 240
Top 100 Xfluencers in Pediatric Hematology/Oncology: Key Opinion Leaders to follow on X (Twitter) in 2024
Jeff Bridges and Lymphoma: How He Went Against, How He Survived, and More
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 5
Familial Adenomatous Polyposis: Alarming Symptoms, Causes, Types, Diagnosis and Treatment
OncoDaily Party Barcelona
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube